書誌事項
- タイトル別名
-
- Analysis of Prognostic Factor in 52 Castration-Resistant Prostate Cancer Treated with Docetaxel
- キョセイ テイコウセイ ゼンリツセンガン ニ タイシ ドセタキセル オ シヨウ シタ 52レイ ノ ヨゴ インシ ノ ケントウ
この論文をさがす
説明
The prognostic factor was retrospectively analyzed in 52 castration-resistant prostate cancer treated with docetaxel (DTX) in our institutions from April, 2006 to August, 2009. The treatment outcomes were decided with prostate specific antigen (PSA) progression-free survival and overall survival. These were calculated by Kaplan-Meier methods and tested with Log-ranktest. Median PSA progression-free survival was 8.8 months and median overall survival was 24.1 months. Prognostic factors on PSA progression were PSA value before DTX treatment and rate of PSA decrement after DTX treatment. Prognostic factors on overall survival were Gleason score (GS), PSA value before DTX treatment, rate of PSA decrement after DTX treatment and positive of bone metastasis in Log-ranktest. Odds ratio of PSA ≧20 ng/ml before DTX treatment was 2.99 and PSA decreasing rate <30% was 3.65. These were statistically significant (p <0.001) riskfactors in the overall survival.
収録刊行物
-
- 泌尿器科紀要
-
泌尿器科紀要 58 (1), 7-11, 2012-01
泌尿器科紀要刊行会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1050282810703102976
-
- NII論文ID
- 40019146683
-
- NII書誌ID
- AN00208315
-
- ISSN
- 00181994
-
- HANDLE
- 2433/153014
-
- NDL書誌ID
- 023408482
-
- 本文言語コード
- ja
-
- 資料種別
- departmental bulletin paper
-
- データソース種別
-
- IRDB
- NDL
- CiNii Articles